ARKG ETF (ARK Genomic Revolution ETF) is managed by Ark Invest with $1.30B in net assets. ARKG expense ratio is 0.75%, holding 35 positions across sectors including Health Care, Information Technology, Unknown. Inception date: 2014-10-31.

ARKG performance shows a YTD return of 2.60%. The 1-year return is 22.24% and the 5-year return is -20.24%.

ARKG top holdings include Tempus Ai (8.8%), Twist Bioscience Corp. (8.7%), Crispr Therapeutics Ag (8.3%), Personalis Inc Com (5.4%), 10X Genomics Inc (5.0%). View all ARKG holdings, sector breakdown, or dividend history.

ARKG can be compared against other funds using the overlap calculator or side-by-side comparison tool. ARKG alternatives are available via the screener, along with tax-loss harvesting opportunities.